NEW YORK (Reuters) - Drugmakers including Pfizer Inc <PFE.N>, GlaxoSmithKline PLC <GSK.L> and Sanofi SA <SASY.PA> are planning to hike U.S. list prices on more than 200 drugs in the United States ...
For decades, governments have criminalized the use of drugs, as well as their possession, production, and distribution. They have poured billions of dollars into pursuing, killing, prosecuting ...
Johnson & Johnson is a global leader in the pharmaceutical, medical device and consumer health care products industries. Its key products include anti-inflammation drug Stelara, multiple myeloma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results